Hepatic sinusoidal obstruction syndrome during chemotherapy for childhood medulloblastoma: Report of a case and review of the literature

Rishi Kotecha, A. Buckland, M.B. Phillips, Catherine Cole, Nicholas Gottardo

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Hepatic sinusoidal obstruction syndrome (HSOS), also known as veno-occlusive disease, is a well-recognized toxic complication after autologous and allogeneic hematopoietic stem cell transplant, during treatment of Wilms tumor and rhabdomyosarcoma associated with actinomycin-D, and during acute lymphoblastic leukemia therapy due to oral 6-thioguanine. However, its occurrence in the context of chemotherapy regimens for other childhood malignancies is rare. We report a 5-year-old girl with high-risk anaplastic medulloblastoma, who developed severe HSOS during her second cycle of maintenance chemotherapy, consisting of vincristine, cisplatin, and cyclophosphamide. She was treated with defibrotide with complete resolution of the HSOS. These findings and a review of the literature, highlight the occurrence of HSOS in children outside the established settings of hematopoietic stem cell transplantation, Wilms tumor, rhabdomyosarcoma, and acute lymphoblastic leukemia. Copyright © 2013 by Lippincott Williams & Wilkins.
Original languageEnglish
Pages (from-to)76-80
JournalJournal of Pediatric Hematology/Oncology
Volume36
Issue number1
DOIs
Publication statusPublished - 2014

Fingerprint Dive into the research topics of 'Hepatic sinusoidal obstruction syndrome during chemotherapy for childhood medulloblastoma: Report of a case and review of the literature'. Together they form a unique fingerprint.

Cite this